Cargando…

Local treatment of synchronous oligometastatic non-small cell lung cancer (NSCLC)—current consensus and future perspectives

Detalles Bibliográficos
Autores principales:	Almeldin, Doaa Said, Malhotra, Jyoti, Patel, Malini, Aisner, Joseph, Jabbour, Salma K.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	AME Publishing Company 2020
Materias:	Editorial Commentary
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7711375/ https://www.ncbi.nlm.nih.gov/pubmed/33282413 http://dx.doi.org/10.21037/jtd-20-1485

Ejemplares similares

Synchronous Oligometastatic Non-small Cell Lung Cancer Managed With Curative-Intent Chemoradiation Therapy: Long-term Outcomes From a Single Institution
por: Yegya-Raman, Nikhil, et al.
Publicado: (2019)

Combining radiation therapy and immunotherapy for lung cancers: a narrative review
por: Modi, Chirag, et al.
Publicado: (2021)

Clinical outcomes and immune phenotypes associated with STK11 co-occurring mutations in non-small cell lung cancer
por: Malhotra, Jyoti, et al.
Publicado: (2022)

Local ablative therapies in oligometastatic NSCLC-upfront or outback?—a narrative review
por: Tjong, Michael C., et al.
Publicado: (2021)

Current Knowledge and Future Perspectives on Awake Bruxism Assessment: Expert Consensus Recommendations
por: Bracci, Alessandro, et al.
Publicado: (2022)

Imaging modalities in synchronous oligometastatic prostate cancer
por: Futterer, Jurgen J., et al.
Publicado: (2018)

Surgical Complexity of Pulmonary Resections Performed for Oligometastatic NSCLC
por: Antonoff, Mara B., et al.
Publicado: (2022)

Commentary: When cancer is oligometastatic, even mesothelioma is curable
por: Abbas, Abbas E.
Publicado: (2020)

SABR in oligometastatic breast cancer: Current status and future directions
por: Stewart, Rachel, et al.
Publicado: (2021)

Genomic features and its potential implication in bone oligometastatic NSCLC
por: Liao, Rongxin, et al.
Publicado: (2023)

Commentary: “Current” consensus: Electrodiagnostics in eye
por: Gaur, Nripen, et al.
Publicado: (2019)

Current Management of Oligometastatic Lung Cancer and Future Perspectives: Results of Thermal Ablation as a Local Ablative Therapy
por: Ghosn, Mario, et al.
Publicado: (2021)

Adjuvant EGFR TKIs in NSCLC harboring EGFR mutations: looking for a consensus way
por: Attili, Ilaria, et al.
Publicado: (2020)

No consensus on implant choice for oligometastatic disease of the femoral head and neck
por: Reif, Taylor J., et al.
Publicado: (2018)

Survival Impact of Aggressive Treatment and PD-L1 Expression in Oligometastatic NSCLC
por: Gauvin, Camille, et al.
Publicado: (2021)

Role of Radiosurgery and Stereotactic Ablative Radiotherapy for Oligometastatic Non-Oncogene Addicted NSCLC
por: Badellino, Serena, et al.
Publicado: (2022)

Management of Synchronous Extrathoracic Oligometastatic Non-Small Cell Lung Cancer
por: Jones, Gregory D., et al.
Publicado: (2021)

Survival Outcomes After Radiotherapy for the Treatment of Synchronous Oligometastatic Prostate Cancer
por: Huynh, Linda My, et al.
Publicado: (2022)

The current and future role of the MRI radiographer in radiation oncology: A collaborative, experiential reflection on the Australian rollout of dedicated MRI simulators
por: Cahoon, Glenn, et al.
Publicado: (2023)

Survival prognostic factors for patients with synchronous brain oligometastatic non-small-cell lung carcinoma receiving local therapy
por: Bai, Hao, et al.
Publicado: (2016)

No consensus about consensus?
por: Kappos, Ludwig
Publicado: (2021)

Transforming the future of health together: The Learning Health Systems Consensus Action Plan
por: Rubin, Joshua C., et al.
Publicado: (2018)

Currently Debated Topics on Surgical Treatment of Pancreatic Ductal Adenocarcinoma: A Narrative Review on Surgical Treatment of Borderline Resectable, Locally Advanced, and Synchronous or Metachronous Oligometastatic Tumor
por: Pedrazzoli, Sergio
Publicado: (2023)

Management of oligometastatic non-small cell lung cancer patients: Current controversies and future directions
por: Couñago, Felipe, et al.
Publicado: (2019)

Radiotherapy for oligometastatic tumor improved the prognosis of patients with non‐small cell lung cancer (NSCLC)
por: Gong, Hong‐yun, et al.
Publicado: (2019)

Definitive Chemoradiation Associated with Improved Survival Outcomes in Patients with Synchronous Oligometastatic Esophageal Cancer
por: Matoska, Thomas, et al.
Publicado: (2023)

Tumor volume reduction evaluated by cone beam computed tomography during stereotactic body radiotherapy for early stage non-small cell lung cancer
por: Gaines, Dakim K., et al.
Publicado: (2020)

Consensus on the Screening, Staging, Treatment, and Surveillance of Localized, Recurrent, and Metastatic Prostate Cancer: The First Global Prostate Cancer Consensus Conference for Developing Countries
por: Maluf, Fernando Cotait, et al.
Publicado: (2021)

Oligometastatic breast cancer: A mini review
por: Rastogi, Sameer, et al.
Publicado: (2014)

Current and future research efforts in oligometastatic non-small cell lung cancer—a systematic review
por: Brandão, Mariana, et al.
Publicado: (2021)

Current and Emerging Treatment Options for Patients with Metastatic EGFR-Mutated Non-small Cell Lung Cancer After Progression on Osimertinib and Platinum-Based Chemotherapy: A Podcast Discussion
por: Patel, Sandip, et al.
Publicado: (2023)

The current role of precision surgery in oligometastatic prostate cancer
por: von Deimling, M., et al.
Publicado: (2022)

Cost-Effectiveness Analysis of Local Treatment in Oligometastatic Disease
por: Mehrens, Dirk, et al.
Publicado: (2021)

Reaching Vulnerable Populations through Portable and Mobile Dentistry—Current and Future Opportunities
por: Gupta, Shailee, et al.
Publicado: (2019)

Robotic treatment of oligometastatic kidney tumor with synchronous pancreatic metastasis: case report and review of the literature
por: Boni, Andrea, et al.
Publicado: (2018)

Evaluation of Concurrent Chemoradiotherapy for Survival Outcomes in Patients With Synchronous Oligometastatic Esophageal Squamous Cell Carcinoma
por: Shi, Zhenguo, et al.
Publicado: (2022)

The metabolic repression effect of carbon-ion radiotherapy in synchronous hormone-sensitive oligometastatic prostate cancer
por: Zhang, Zhenshan, et al.
Publicado: (2023)

Future Directions for Dementia Risk Reduction and Prevention Research: An International Research Network on Dementia Prevention Consensus
por: Anstey, Kaarin J., et al.
Publicado: (2020)

Multimodal therapy in oligometastatic prostate cancer: A glimpse into the future?
por: Knipper, Sophie, et al.
Publicado: (2021)

PET-Plan: potential for dose escalation by target volume reduction in locally advanced NSCLC
por: de Jong, Evelyn E. C., et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_1cuciokcd4naetaf5ddn6ldh8c